(Total Views: 251)
Posted On: 01/02/2018 10:54:13 PM
Post# of 99130
Share a thought on $RVXCF
https://investorshangout.com/Resverlogix-Corp-RVXCF-66357/
Resverlogix is a clinical stage biotech with its lead compound, Apabetalone, in a phase III trial. In fact this event based trial has been running for over 2 years with 5 positive reccomendations from the independent Data Safety Monitoring Board (DSMB) monitoring the trial, with no safety or efficacy issues.
Apabetalone has been validated by Pfizer which included the compound in a patent application for the treatment of a rare disease called Friedreich's Ataxia:
https://friedreichsataxianews.com/2017/05/25/...developed/
https://investorshangout.com/Resverlogix-Corp-RVXCF-66357/
Resverlogix is a clinical stage biotech with its lead compound, Apabetalone, in a phase III trial. In fact this event based trial has been running for over 2 years with 5 positive reccomendations from the independent Data Safety Monitoring Board (DSMB) monitoring the trial, with no safety or efficacy issues.
Apabetalone has been validated by Pfizer which included the compound in a patent application for the treatment of a rare disease called Friedreich's Ataxia:
https://friedreichsataxianews.com/2017/05/25/...developed/
(0)
(0)
Check out my blog if you like: Avoid The Bag
